Korsana Biosciences (KRSA) Accumulated Expenses (2018 - 2025)
Korsana Biosciences' Accumulated Expenses came in at $198,000 for Q4 2025, down 30.0% from $283,000 a year earlier and down 43.6% from the prior quarter.
Powered by 
Analysis
Korsana Biosciences (KRSA) Accumulated Expenses (2018 - 2025) Analysis & Trends
Going back to Q4 2018, Korsana Biosciences' Accumulated Expenses data covers 29 quarters.
- Accumulated Expenses has declined in each of the last seven years, with a five-year compound annual growth rate of -51.4% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $283,000 in FY2024 (-64.5%), $798,000 in FY2023 (-66.5%), $2.38 million in FY2022 (-62.5%) and $6.35 million in FY2021 (-12.9%).
- The Q4 2025 figure represents the lowest quarterly Accumulated Expenses in data going back to Q4 2018.
- Year-over-year, Accumulated Expenses increased in 1 of the last eight quarters, with an average decline of 46.1%.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q2 2022 (growth of 41.0%), and the weakest in Q2 2024 (a decline of 78.3%).
- Business Quant data shows KRSA's Accumulated Expenses at $351,000 (Q3 2025), $266,000 (Q2 2025) and $534,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Korsana Biosciences | 16.89 Mn | 2.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 198,000.00 |
| Sep 30, 2025 | 351,000.00 |
| Jun 30, 2025 | 266,000.00 |
| Mar 31, 2025 | 534,000.00 |
| Dec 31, 2024 | 283,000.00 |
| Sep 30, 2024 | 324,000.00 |
| Jun 30, 2024 | 534,000.00 |
| Mar 31, 2024 | 610,000.00 |
| Dec 31, 2023 | 798,000.00 |
| Sep 30, 2023 | 1.17 Mn |
| Jun 30, 2023 | 2.46 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 2.38 Mn |
| Sep 30, 2022 | 4.32 Mn |
| Jun 30, 2022 | 4.76 Mn |
| Mar 31, 2022 | 4.54 Mn |
| Dec 31, 2021 | 6.35 Mn |
| Sep 30, 2021 | 3.43 Mn |
| Jun 30, 2021 | 3.38 Mn |
| Mar 31, 2021 | 3.86 Mn |
API Access
Korsana Biosciences Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=KRSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "KRSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=KRSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();